nach oben

Supportive Care in Cancer

Erschienen in:

01.03.2014 | Original Article

How breast cancer survivors cope with fear of recurrence: a focus group study

verfasst von: Jolanda De Vries, Brenda L. Den Oudsten, Patty M. E. P. Jacobs, Jan A. Roukema

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this qualitative study was to examine the ways in which breast cancer survivors cope with fear of recurrence.

Methods

Three focus groups were held with breast cancer survivors. Focus group interviews were recorded, transcribed verbatim, and analyzed using qualitative techniques. Coding was done on two levels: styles and strategies.

Results

Twenty-seven women participated. The majority of the women (74 %) were a little anxious, and some patients (11 %) were somewhat anxious about the possibility of cancer recurrence. Most women (74 %) indicated to think a few times a month about the possibility of cancer recurrence. Different coping styles were reported, but commonly, women (80 %) reported an emotion-focused coping strategy. About half of the women (49 %) used passive or avoidant coping styles.

Conclusion

The emotion-focused coping strategy was most commonly used. This information can be used to provide tailored psychosocial care.

Intergraal Kanker Centrum Nederland (2011) Meest voorkomende kankersoorten in Nederland. [Most common cancer types in the Netherlands]. http://www.ikcnet.nl/page.php?id=2985&nav_id=114. Accessed 11 Feb 2013

Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781. doi:10.1016/j.ejca.2009.12.014 PubMedCrossRef

DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61:409–418. doi:10.3322/caac.20134 PubMedCrossRef

Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C (2012) The decline in breast cancer mortality in Europe: an update (to 2009). Breast 21:77–82. doi:10.1016/j.breast.2011.08.001 PubMedCrossRef

Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA, Jemal A, Ahmed F, Cobb N, Kaur JS, Edwards BK (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110:2119–2152. doi:10.1002/cncr.23044 PubMedCrossRef

Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4:251–254. doi:10.1016/S1470-2045(03)01037-4 PubMedCrossRef

Signaleringcommissie Kanker (2011) Kanker in Nederland tot 2020: Trends en prognoses [Cancer in the Netherlands until 2020: trends and prognoses]. KWF Kankerbestrijding, Oisterwijk

Khan F, Amatya B, Pallant JF, Rajapaksa I (2012) Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast 21:314–320. doi:10.1016/j.breast.2012.01.013 PubMedCrossRef

Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M (2013) Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer 21:901–906. doi:10.1007/s00520-012-1685-3 PubMedCrossRef

10.

Connell S, Patterson C, Newman B (2006) Issues and concerns of young Australian women with breast cancer. Support Care Cancer 14:419–426. doi:10.1007/s00520-005-0003-8 PubMedCrossRef

11.

Vickberg SM (2003) The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 25:16–24PubMedCrossRef

12.

Costanzo ES, Lutgendorf SK, Mattes ML, Trehan S, Robinson CB, Tewfik F, Roman SL (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97:1625–1631. doi:10.1038/sj.bjc.6604091 PubMedCentralPubMedCrossRef

13.

Johnson Vickberg SM (2001) Fears about breast cancer recurrence. Cancer Pract 9:237–243. doi:10.1046/j.1523-5394.2001.009005237.x PubMedCrossRef

14.

Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B (2006) Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 15:306–320. doi:10.1002/pon.955 PubMedCrossRef

15.

Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB (2011) Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 130:165–173. doi:10.1007/s10549-011-1551-x PubMedCentralPubMedCrossRef

16.

van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J (2008) Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology 17:1137–1145. doi:10.1002/pon.1340 PubMedCrossRef

17.

Lazarus RS, Folkman S (1984) Stress, appraisal, and coping. Springer, New York

18.

Folkman S, Lazarus RS, Dunkel-Schetter C, DeLongis A, Gruen RJ (1986) Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol 50:992–1003PubMedCrossRef

19.

Cervone D, Pervin LA (2008) Personality: Theory and research. Wiley, Chichester

20.

Fredette SL (1995) Breast cancer survivors: concerns and coping. Cancer Nurs 18:35–46PubMedCrossRef

21.

McGinty HL, Goldenberg JL, Jacobsen PB (2012) Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psychooncology 21:203–210. doi:10.1002/pon.1883 PubMedCrossRef

22.

Lauver DR, Connolly-Nelson K, Vang P (2007) Stressors and coping strategies among female cancer survivors after treatments. Cancer Nurs 30:101–111. doi:10.1097/01.NCC.0000265003.56817.2c PubMedCrossRef

23.

Stanton AL, Danoff-Burg S, Huggins ME (2002) The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology 11:93–102. doi:10.1002/pon.574 PubMedCrossRef

24.

Krueger RA (2006) Is it a focus group? Tips on how to tell. J Wound Ostomy Continence Nurs 33:363–366PubMedCrossRef

25.

Sim J (1998) Collecting and analysing qualitative data: issues raised by the focus group. J Adv Nurs 28:345–352. doi:10.1046/j.1365-2648.1998.00692.x PubMedCrossRef

26.

Krueger RA, Casey MA (2000) Focus groups: A practical guide for applied research. Sage Publications, Thousand Oaks

27.

Morgan DL (1997) Focus groups as qualitative research. Sage, London

28.

Simard S, Savard J (2009) Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251. doi:10.1007/s00520-008-0444-y PubMedCrossRef

29.

Baarda, De Goede, Teunissen (2005) Hoe analyseer ik mijn kwalitatieve gegevens? [How do I analyse my qualitative data?] Basisboek Kwalitatief Onderzoek. Stenfert Kroese, Groningen

30.

Krueger RA (2006) Analyzing focus group interviews. J Wound Ostomy Continence Nurs 33:478–481PubMedCrossRef

31.

Koch L, Jansen L, Brenner H, Arndt V (2013) Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology 22:1–11. doi:10.1016/j.ejca.2010.06.010 PubMedCrossRef

32.

Roth S, Cohen LJ (1986) Approach, avoidance, and coping with stress. Am Psychol 41:813–819PubMedCrossRef

33.

Lazarus RS, DeLongis A (1983) Psychological stress and coping in aging. Am Psychol 38:245–254PubMedCrossRef

34.

Lambert SD, Girgis A, McElduff P, Turner J, Levesque J, Kayser K et al (2013) A parallel-group, randomised controlled trial of a multimedia, self-directed coping skills training intervention for patients with cancer and their partners: design and rationale. BMJ Open 3(7):1–12CrossRef

35.

Lengacher CA, Johnson-Mallard V, Barta M et al (2011) Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs 29(2):107–117. doi:10.1177/0898010110385938 PubMedCrossRef

36.

Lengacher CA, Johnson-Mallard V, Post-White J et al (2009) Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology 18(12):1261–1272PubMedCrossRef

37.

Lengacher CA, Reich RR, Post-White J et al (2012) Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters. J Behav Med 35(1):86–94. doi:10.1007/s10865-011-9346-4 PubMedCrossRef

38.

Shields CG, Ziner KW, Bourff SA et al (2010) An intervention to improve communication between breast cancer survivors and their physicians. J Psychosoc Oncol 28(6):610–629PubMedCentralPubMedCrossRef

39.

Weisman AD, Sobel HJ (1979) Coping with cancer through self-instruction: a hypothesis. J Hum Stress 5:3–8CrossRef

40.

Chaturvedi SK, Peter Maguire G, Somashekar BS (2006) Somatization in cancer. Int Rev Psychiatry 18:49–54. doi:10.1080/09540260500466881 PubMedCrossRef

Titel: How breast cancer survivors cope with fear of recurrence: a focus group study
verfasst von: Jolanda De Vries
Brenda L. Den Oudsten
Patty M. E. P. Jacobs
Jan A. Roukema
Publikationsdatum: 01.03.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 3/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-013-2025-y

Neu im Fachgebiet Onkologie

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

How breast cancer survivors cope with fear of recurrence: a focus group study

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

Update Onkologie

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain

Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients

Reasons for hospitalisation at the end of life: differences between cancer and non-cancer patients

Handling uncertainty

The sexual health care needs after colorectal cancer: the view of patients, partners, and health care professionals

Psychometric evaluation of the Sibling Cancer Needs Instrument (SCNI): an instrument to assess the psychosocial unmet needs of young people who are siblings of cancer patients

Neu im Fachgebiet Onkologie

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

Update Onkologie